Josef Schoell, Chief Financial Officer at Cara Therapeutics, Inc. (CARA), bought 3,000 shares at $22.10 ($66K) on 2015-08-18, disclosed to the SEC on 2015-08-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.